Protalix BioTherapeutics, Inc.
Insider Ownership
| 8-K | 34 | 04/23/2025 | 04/21/2025 |
| 8-K | 34 | 12/23/2024 | 12/23/2024 |
| 10-Q | 34 | 11/14/2024 | 09/30/2024 |
| 8-K | 34 | 11/14/2024 | 11/14/2024 |
| 8-K | 34 | 10/25/2024 | 10/25/2024 |
| 10-Q | 34 | 08/14/2024 | 06/30/2024 |
| 8-K | 34 | 08/14/2024 | 08/14/2024 |
| 10-Q | 34 | 05/10/2024 | 03/31/2024 |
| 8-K | 34 | 05/10/2024 | 05/10/2024 |
| 10-K | 34 | 03/14/2024 | 12/31/2023 |
≥5% Ownership
| 4/A | 11/05/2024 | 09/23/2024 | |
| 4 | 09/24/2024 | 09/23/2024 | |
| 4 | 09/24/2024 | 09/23/2024 | |
| 4 | 04/03/2024 | 04/01/2023 | |
| 4 | 10/20/2023 | 10/19/2023 | |
| 4 | 10/03/2023 | 09/29/2023 | |
| 4 | 10/03/2023 | 09/29/2023 | |
| 4 | 10/03/2023 | 09/29/2023 | |
| 4 | 10/03/2023 | 09/29/2023 | |
| 4 | 10/03/2023 | 09/29/2023 |